IP Library Granted Patent US 9,725,740
Granted Patent B2
US 9,725,740 · App. 15/160,662 · Granted Aug 8, 2017

Sclareol and labdenediol diphosphate synthase polypeptides, encoding nucleic acid molecules and uses thereof

Inventors: Grace Eunyoung Park (Lexington, KY); Bryan N. Julien (Lexington, KY); Richard Burlingame (Nicholasville, KY)
Assignee: EVOLVA, INC.
C12P7/02C12N9/88C12P7/18C12P9/00C12Y402/03Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,725,740
App. No.
15/160,662
Granted
Aug 8, 2017
Kind
B2
Abstract

Provided are labdenediol diphosphate synthase polypeptides, sclareol synthase polypeptides, nucleic acid molecules encoding the labdenediol diphosphate synthase polypeptides and sclareol synthase polypeptides, and methods of using the labdenediol diphosphate synthase polypeptides, sclareol synthase polypeptides. Also provided are methods for producing labdenediol diphosphate, sclareol and (−)-ambroxide.

Claims (24)

1. An isolated nucleic acid molecule encoding a sclareol synthase polypeptide;

wherein the nucleic acid molecule is cDNA;

wherein the sclareol synthase polypeptide comprises a sequence of amino acid residues that has at least 85% identity to SEQ ID NO:31, 36, 38, 40, 78, or 86; and

wherein the sclareol synthase polypeptide catalyzes the formation of sclareol from labdenediol diphosphate.

2. The isolated nucleic acid molecule of claim 1 , comprising a sequence of nucleic acids set forth in any of SEQ ID NOS:30, 35, 37, 39, 77, or 87.

3. A host cell comprising a nucleic acid molecule encoding a sclareol synthase polypeptide,

wherein the sclareol synthase is heterologous to the host cell;

wherein the sclareol synthase polypeptide comprises a sequence of amino acid residues that has at least 85% identity to SEQ ID NO:31, 36, 38, 40, 78, or 86; and

wherein the sclareol synthase catalyzes production of a terpene from labdenediol diphosphate in the host cell.

4. The host cell of claim 3 , wherein:

the sclareol synthase polypeptide comprises a sequence of amino acids set forth in any of SEQ ID NOS: 31, 36, 38, 40, 78, or 86.

5. The host cell of claim 3 , wherein the host cell comprises a nucleic acid encoding a geranylgeranyl diphosphate (GGPP) synthase that catalyzes production of the GGPP.

6. The host cell of claim 3 , wherein the host cell is a yeast cell.

7. The isolated nucleic acid molecule of claim 1 or the host cell of claim 3 , wherein the encoded sclareol synthase polypeptide comprises one or more heterologous domains or portions thereof from one or more terpene synthases, wherein the domain is Loop 1; Helix A; Loop 2; Helix B; Loop 3; Helix C; Loop 4; Helix D; Loop 5; Helix E; Loop 6; Helix F; Loop 7; Helix G; Loop 8; Helix H; Loop 9; Helix I; Loop 10; Helix J; Loop 11; Helix K; Loop 12; Helix L; Loop 13; Helix M; Loop 14; Helix N; Loop 15; Helix O; Loop 16; Helix P; Loop 17; Helix Q; Loop 18; Helix R; Loop 19; Helix S; Loop 20; Helix T; Loop 21; Helix U; Loop 22; Helix V; Loop 23; Helix W; Loop 24; Helix X; Loop 25; Helix Y; Loop 26; Helix Z; Loop 27; Helix AA; Loop 28; Helix AB; Loop 29; Helix AC; Loop 30; Helix AD; Loop 31; Helix AE; Loop 32; Helix AF; Loop 33; Helix AG; Loop 34; Helix AH; or Loop 35.

8. A method for producing sclareol comprising:

contacting labdenediol diphosphate with the host cell of claim 3 to produce sclareol;

and optionally, isolating the sclareol; wherein:

the sclareol synthase polypeptide encoded by the host cell is expressed; and

the sclareol synthase polypeptide catalyzes the formation of sclareol from labdenediol diphosphate.

9. A vector comprising a cDNA molecule encoding a sclareol synthase polypeptide;

wherein the sclareol synthase polypeptide comprises a sequence of amino acid residues that has at least 85% sequence identity to the sclareol synthase polypeptide set forth in SEQ ID NO: 31, 36, 38, 40, 78, or 86.

10. The vector of claim 9 , wherein the vector is a prokaryotic vector, a viral vector, or a eukaryotic vector.

11. The vector of claim 9 , wherein the vector is a yeast vector.

12. A host cell comprising the vector of claim 11 .

Assignments (3)
MERGER AND CHANGE OF NAME Recorded May 15, 2024
From: EVOLVA, INC.; MINNESOTA SPECIALTY YEAST LLC
To: MINNESOTA SPECIALTY YEAST LLC
Reel/Frame 067415/0084 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2017
From: PARK, GRACE EUNYOUNG; JULIEN, BRYAN N.; BURLINGAME, RICHARD
To: ALLYLIX, INC.
Reel/Frame 041277/0944 →
MERGER AND CHANGE OF NAME Recorded Feb 16, 2017
From: ALLYLIX INC.; ALLYLIX INC.
To: EVOLVA, INC.
Reel/Frame 041278/0118 →
Continuity (3)
Division 13987493 · Jul 30, 2013
Provisional Application 61741959 · Jul 30, 2012
Related Publication 20160265002A1 · Sep 15, 2016